Summary: Ajeet Seeds Private Limited challenged Regulation 6 of the 2023 Regulations by the National Medical Commission (NMC) in the Bombay High Court. They argued it was unconstitutional and hurt their plans to establish a medical college in Maharashtra.
In March 2021, Ajeet Seeds Private Limited decided to build a hospital and medical college in Chhatrapati Sambhajinagar, Maharashtra. They invested a huge ₹355 crores and hired 723 staff to start this project.
Everything was going smoothly until the National Medical Commission (NMC) introduced Regulation 6 in 2023. This rule required that only Section 8 Companies could start new medical colleges. Ajeet Seeds, being a Private Limited Company, found this rule unfair and a major obstacle.
Ajeet Seeds filed a request in the Bombay High Court. They argued that Regulation 6 was beyond what the NMC was allowed to do and violated Articles 14 and 19 of the Indian Constitution. They wanted the court to cancel this rule and let them continue with their plans.
"Regulation 6 of the 2023 Regulations is unconstitutional and beyond legal authority," argued Mr. V.D. Sapkal, the senior lawyer for Ajeet Seeds.
The case was heard by Judges Sandipkumar C. More and Abasaheb D. Shinde. On January 28, 2026, the court ruled in favor of the NMC. They decided that Regulation 6 was valid and aimed at ensuring medical education was not profit-driven.
The court found that the rule was consistent with the NMC Act's goal to maintain high standards in medical education. They believed allowing only Section 8 Companies would prevent commercial exploitation in medical education.
"The regulation ensures that medical education remains aligned with broader public interest," the court noted.
The court dismissed Ajeet Seeds' request. This decision means that Regulation 6 stays in place, ensuring that only certain types of companies can start medical colleges to keep education focused on the public good.
